Model Number PB1018 |
Device Problems
Fracture (1260); Occlusion Within Device (1423); Structural Problem (2506)
|
Patient Problems
Pulmonary Regurgitation (2023); Thrombus (2101); Stenosis (2263)
|
Event Date 02/24/2014 |
Event Type
Injury
|
Manufacturer Narrative
|
Additional information was received that 35 months post-implant, wide complex ventricular tachycardia (vt) was noted via electrocardiogram (ecg) after symptoms of a fast heartbeat during exercise.Cardioversion was performed successfully, however short bursts of vt continued until an implantable cardioverter defibrillator (icd) was implanted the same day of the valve explant.No adverse patient effects were reported.Conclusion: conduction disturbances are known potential adverse effects associated with any cardiac or thoracic procedure (open or c atheter-based) and can be resolved with medical treatment or the implant of a permanent pacemaker (with the risk-benefit ratio in favor of implant of the percutaneous aortic valve).A conduction disturbance does not indicate a device malfunction or potential manuf acturing issue.(b)(4).
|
|
Event Description
|
Medtronic received information that three years post implant of this transcatheter pulmonary bioprosthetic valve, mixed stenosis and regurgitation was observed.A type one fracture was noted under fluoroscopy.The stent appeared more oval shaped compared to previous fluoroscopy images.The valve and previously implanted 20mm contegra conduit were surgically removed due to the patient's increased in size with age (the contegra conduit would not dilate beyond the 20 mm size), a new non-medtronic 27mm surgical valve was implanted.No adverse patient effects were reported.The transcatheter bioprosthetic valve will be returned for analysis.
|
|
Manufacturer Narrative
|
The product has not been returned for analysis.Without the return of the product, no definitive conclusion can be made regarding the clinical observation.Should the product be returned, a follow-up report will be submitted.(b)(4).
|
|
Manufacturer Narrative
|
Upon receipt at medtronic¿s quality laboratory, the device appeared to have been cut into two pieces longitudinally through two leaflets.An unknown bare metal stent this device appeared to have been deployed within remained attached to the melody valve.Due to the receipt condition of the device, the reported stent fracture and oval shape could not be verified.All leaflets were slightly stiff but flexible.Cuts on the existing leaflets appeared to have occurred during explant.Two commissures were intact.Glistening off-white pannus lined the outflow orifice, extending approximately 1 to 5 mm into the inner lumen.The device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Reduced performance of the valve was attributed to host tissue overgrowth (pannus).This finding is generally considered a patient-related condition.
|
|
Manufacturer Narrative
|
Additional information was received from the pathology report that there was a small amount of thrombus on the cusps of the valve.No adverse patient effects were reported.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Conclusion: the pathology analysis reported thrombus.Thrombus could cause the immobile leaflet and lead to stenosis.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|